share_log

ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7

ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7

ThinkEquity以買入評級啟動對Vivani Medical的報道,宣佈目標價為7美元
Benzinga Real-time News ·  2022/12/05 09:18

ThinkEquity analyst Ashok Kumar initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $7.

ThinkEquity分析師Ashok Kumar對Vivani Medical(納斯達克:VANI)進行了買入評級,並宣佈目標價為7美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論